These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 2497928)
1. Effect of striatal implantation of bovine adrenal chromaffin cells on turning behavior in a rat model of Parkinson's disease. Fitzgerald LR; Glick SD; Schneider AS Brain Res; 1989 Mar; 481(2):373-7. PubMed ID: 2497928 [TBL] [Abstract][Full Text] [Related]
2. Transplantation of cultured human adrenal chromaffin cells into 6-hydroxydopamine-lesioned rat brain. Kamo H; Kim SU; McGeer PL; Tago H; Shin DH Synapse; 1987; 1(4):324-8. PubMed ID: 2901789 [TBL] [Abstract][Full Text] [Related]
4. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation. Shapiro RM; Glick SD; Camarota NA Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711 [TBL] [Abstract][Full Text] [Related]
5. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. Yuan H; Sarre S; Ebinger G; Michotte Y J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237 [TBL] [Abstract][Full Text] [Related]
6. Adrenal medullary graft to brain in 6-hydroxydopamine-lesioned rotation rats. Comparison of two different graft sites (striatum versus lateral ventricle) by behavioral observation and fluorescence histochemistry. Torigoe R; Yoshida M; Ohtsuru K; Kuga S; Kuramoto S Stereotact Funct Neurosurg; 1990; 54-55():347-52. PubMed ID: 2127861 [TBL] [Abstract][Full Text] [Related]
7. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats. Borlongan CV; Saporta S; Sanberg PR Exp Neurol; 1998 Jun; 151(2):203-14. PubMed ID: 9628755 [TBL] [Abstract][Full Text] [Related]
8. Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability. Schueler SB; Ortega JD; Sagen J; Kordower JH J Neurosci; 1993 Oct; 13(10):4496-510. PubMed ID: 8105042 [TBL] [Abstract][Full Text] [Related]
9. Cografts of adrenal medulla with C6 glioma cells in rats with 6-hydroxydopamine-induced lesions. Bing G; Notter MF; Hansen JT; Kellogg C; Kordower JH; Gash DM Neuroscience; 1990; 34(3):687-97. PubMed ID: 1972269 [TBL] [Abstract][Full Text] [Related]
10. Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions. Becker JB; Freed WJ Brain Res; 1988 Oct; 462(2):401-6. PubMed ID: 3142637 [TBL] [Abstract][Full Text] [Related]
11. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism. Friehs GM; Parker RG; He LS; Haines SJ; Turner DA; Ebner TJ J Neural Transplant Plast; 1991; 2(2):141-56. PubMed ID: 1684115 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic neuronal sprouting and behavioral recovery in hemi-parkinsonian rats after implantation of amnion cells. Sheng JG; McShane LM; Plunkett RJ; Cummins AC; Oldfield EH; Kopin IJ; Palmatier MA Exp Neurol; 1993 Oct; 123(2):192-203. PubMed ID: 8405285 [TBL] [Abstract][Full Text] [Related]
13. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats. Robertson GS; Fine A; Robertson HA Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908 [TBL] [Abstract][Full Text] [Related]
15. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234 [TBL] [Abstract][Full Text] [Related]
16. Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo. Hanke M; Farkas LM; Jakob M; Ries R; Pohl J; Sullivan AM Neuroscience; 2004; 124(4):757-66. PubMed ID: 15026116 [TBL] [Abstract][Full Text] [Related]
17. Amphetamine- and stress-induced turning after nigral transplants in neonatally dopamine-depleted rats. Carder RK; Snyder-Keller AM; Lund RD Brain Res; 1987 Jun; 430(2):315-8. PubMed ID: 2886195 [TBL] [Abstract][Full Text] [Related]
18. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease. Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838 [TBL] [Abstract][Full Text] [Related]
19. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease. Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease. Yuan H; Sarre S; Ebinger G; Michotte Y Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]